Real Decision Scenarios in the Fertility Clinic
In a reproductive medicine clinic, when a patient diagnosed with ovarian failure asks whether she can undergo IVF in Georgia, the doctor's decision-making logic is not simply to answer "yes" or "no," but first to clarify the following core issues: To what extent has ovarian function failed? Is there any follicular activity? Has ovulation induction been attempted before? What is the patient's age and overall health status? Only after clarifying this basic information can the feasibility of IVF in Georgia be discussed.
Direct Answer: When It Is Suitable and When It Is Not
Suitable situations:
- Complete ovarian failure (AMH < 0.1 ng/mL, FSH > 40 IU/L, no antral follicles), requiring a donor egg plan, and Georgia law permits donor egg IVF.
- Residual follicular activity remains, but multiple previous ovulation induction attempts in the home country have failed, and the patient wishes to try different stimulation protocols (e.g., mild stimulation or natural cycle).
- Need for donor egg or surrogacy services, and desire lower costs compared to countries like the United States or the United Kingdom.
Unsuitable situations:
- Comprehensive fertility assessment has not been completed, and the patient is unaware of her true ovarian status.
- Ethical or psychological concerns about donor egg plans; inability to accept non-genetic eggs.
- Limited financial resources without understanding the total cost structure (medical fees, travel, accommodation, translation, etc.).
- Uncontrolled autoimmune disease or endometrial pathology that requires priority treatment.
Reproductive Specialist's Evaluation Logic
From a reproductive medicine perspective, a doctor evaluates whether an ovarian failure patient is suitable for IVF in Georgia based on the following key points:
1. Precise Assessment of Ovarian Reserve
A diagnosis cannot be based solely on a single elevated FSH level. Continuous monitoring of FSH, LH, and E2, combined with AMH and transvaginal ultrasound antral follicle count, is necessary. If AMH < 0.1 ng/mL and antral follicle count < 2, the success rate with own eggs is typically below 5%, making donor eggs a more practical option.
2. History of Previous Ovulation Induction Response
If a patient has previously used high-dose stimulation medications (e.g., 300-450 IU daily) with no follicular growth, or has only obtained 1-2 eggs of poor quality, further attempts with own eggs are of limited value.
3. Age Factor
Although ovarian failure patients may be chronologically younger, the rate of egg aging is related to age. Ovarian failure patients under 35 who still have intermittent ovulation have a slightly higher chance of success with own eggs than those over 35.
4. Etiology Investigation
Ovarian failure can be caused by genetic factors (e.g., X chromosome abnormalities), autoimmune diseases, previous surgery, or chemotherapy/radiotherapy. Different etiologies influence the choice of treatment plan.
Interpretation of Key Diagnostic Indicators
| Indicator | Normal Range | Ovarian Failure Criteria | Clinical Significance |
|---|---|---|---|
| AMH | >1.0 ng/mL | <0.1 ng/mL | Direct marker of ovarian reserve; very low indicates follicular depletion |
| FSH | <10 IU/L | >40 IU/L | Elevated with declining ovarian function; requires confirmation with repeat testing after 4 weeks |
| LH | 5-20 IU/L | >30 IU/L | Often rises synchronously with FSH in ovarian failure |
| Antral Follicle Count | >10 | <2 | Number of visible follicles on ultrasound; directly reflects ovarian responsiveness |
| Estradiol (E2) | 30-100 pg/mL | <20 pg/mL | Very low levels indicate ovarian failure |
For ovarian failure patients, it is recommended to have blood drawn on days 2-4 of the menstrual cycle along with a transvaginal ultrasound. If amenorrhea is present, random testing can be done, but results must be interpreted with continuous monitoring.
Differences in Legal and Medical Environments Across Countries
| Country | Donor Egg Law | Surrogacy Law | Cost Range (Donor Egg Cycle) | Laboratory Standard Assessment |
|---|---|---|---|---|
| Georgia | Permitted, clear legal framework | Permitted | 80,000 - 150,000 RMB | Requires on-site evaluation; some centers meet European standards |
| United States | Permitted, well-established laws | Varies by state | 200,000 - 400,000 RMB | Generally high standard with certification systems |
| Ukraine | Permitted | Legally gray | 70,000 - 120,000 RMB | Variable quality |
| Domestic (China) | Strictly restricted | Prohibited | 30,000 - 70,000 RMB (own eggs) | Reliable standard at tertiary hospitals |
Georgia has advantages in the legality of donor eggs and cost, but embryo culture techniques, vitrification efficiency, and PGT capabilities vary among different fertility centers. It is recommended to request the center's data from the last 2 years for donor egg cycles, including cleavage rate, blastocyst formation rate, implantation rate, and live birth rate.
Easily Overlooked Details
- Waiting time for donor egg resources: Donor egg sources in Georgia include local and Eastern European donors. Matching waiting times range from 1 month to half a year. Confirm whether the center has an existing egg bank or recruits donors on demand.
- Vitrification technology in the embryology lab: For ovarian failure patients, even when using donor eggs, the quality of egg or embryo cryopreservation directly affects outcomes. Confirm whether the lab uses closed vitrification carriers and standardized vitrification protocols.
- Endometrial preparation before transfer: Ovarian failure patients typically lack natural cycles, so endometrial preparation relies entirely on hormone replacement. Endometrial thickness, pattern, and blood flow must be assessed before transfer. If the endometrium is <7 mm or has poor pattern, the cancellation rate is high.
- Luteal phase support protocol: In donor egg cycles, luteal function depends entirely on exogenous progesterone. Different centers use different progesterone formulations (intramuscular, vaginal gel, oral) and dosages. Confirm whether a standardized luteal support protocol exists.
- Necessity of chromosome screening: Although donor eggs come from young donors, PGT-A screening can still reduce the risk of embryonic chromosomal abnormalities. It is especially recommended for patients with recurrent implantation failure or a history of miscarriage.
Common Pitfalls
- Being promised "success with own eggs": Some agencies promise "personalized stimulation protocols" to obtain eggs from ovarian failure patients, but the actual success rate is extremely low, leading to significant time and financial loss without usable embryos. For patients with AMH<0.1 and FSH>40, donor egg options should be discussed directly.
- Not understanding legal restrictions on donor eggs: Georgia permits donor eggs, but regulations regarding donor anonymity, donation limits, and the child's future right to know vary among centers.
- Skipping chromosome screening: Donor egg cycles are costly, and some patients skip PGT to save money, leading to miscarriage or repeated failure after transfer. PGT-A can significantly improve the success rate per transfer and reduce overall costs.
- Unrealistic expectations of success rates: Live birth rates for donor egg cycles can reach 40-60% (depending on donor age and lab standards), but are not 100%. Patients need to be mentally and financially prepared.
- Not considering visa and travel restrictions: Georgia has a visa-free policy for Chinese citizens, but the duration of each stay is limited. Treatment cycles usually require 2-3 round trips, so visa policies and travel arrangements must be confirmed.
Timeline: From Evaluation to Transfer
For ovarian failure patients, the complete timeline for IVF in Georgia typically includes the following stages:
- Pre-assessment (completed domestically, 1-2 weeks): Complete AMH, FSH, LH, E2, thyroid function, autoimmune antibodies, karyotype, hysteroscopy, and male semen analysis. Also, ensure passport validity (>6 months).
- Remote consultation and center selection (2-4 weeks): Communicate with 2-3 Georgian fertility centers online to understand their donor egg resources, success rates, and cost structures. Request written treatment plans and detailed fee schedules.
- First trip to Georgia (7-10 days): Complete registration, sign informed consent, undergo gynecological examination (hysteroscopy, endometrial biopsy), and freeze a semen sample. If using eggs from an egg bank, donor matching can begin simultaneously.
- Donor matching and embryo culture (1-6 months): Waiting time depends on the center's egg bank size and matching efficiency. After matching, the donor undergoes ovulation induction, eggs are retrieved for ICSI with the partner's sperm, embryos are cultured for 5-6 days, PGT-A is performed (if chosen), and then embryos are frozen.
- Second trip to Georgia for transfer (10-14 days): After confirming embryo availability, prepare the endometrium with a hormone replacement cycle. Pregnancy test via blood draw 9-12 days after transfer. If pregnant, continue luteal support until 10 weeks of gestation.
- Follow-up: Early pregnancy monitoring can be done locally or upon returning home. After confirming fetal heartbeat, management can be transferred to a domestic doctor.
Special Situations
Ovarian Failure Patients with Intermittent Ovulation
About 5-10% of ovarian failure patients experience occasional ovulation. In such cases, natural cycle or mild stimulation protocols can be attempted. If follicular development is detected on ultrasound, egg retrieval can be performed. However, the number of eggs retrieved per cycle is usually only 1-2, requiring patience to accumulate. Some Georgian centers offer "cumulative egg/embryo freezing" services suitable for these patients.
Concurrent Autoimmune Disease
Autoimmune ovarian failure is often accompanied by thyroiditis, adrenalitis, etc. Before IVF, the primary disease must be controlled and immunosuppressant dosages adjusted. Before transfer, assess whether there is immune cell infiltration in the endometrium, and consider immunotherapy if necessary.
Previous Ovarian Surgery
Ovarian failure following ovarian cystectomy or oophorectomy may involve impaired ovarian blood flow. These patients respond even worse to ovulation induction drugs, making donor egg plans more realistic. Preoperative assessment of residual ovarian volume and blood flow signals is necessary.
Concurrent Male Factor
If the male partner has severe oligoasthenospermia or chromosomal abnormalities, ICSI and PGT are required simultaneously. Some Georgian centers offer one-stop services, but it is essential to confirm the lab's technical capabilities.
Risk Reminders
Before choosing IVF in Georgia, ovarian failure patients need to fully understand the following risks:
- Donor egg plans mean the child will not be genetically related to the female partner; psychological and family preparation is necessary.
- Overseas medical care involves communication costs, legal differences, and challenges with post-treatment follow-up.
- The laboratory standards of some Georgian fertility centers may not meet international accreditation criteria. It is recommended to request EQA (External Quality Assessment) reports or success rate data from the last 2 years.
- Cost structures may not be transparent. Before signing a contract, confirm whether it includes donor compensation, PGT fees, transfer fees, and refund policies in case of failure.
- Even with donor eggs, approximately 30-40% of cycles do not result in a live birth. Patients should have a contingency plan for failure.
It is recommended to complete all basic tests before departure and maintain communication with a domestic reproductive doctor to ensure the overseas treatment plan aligns with domestic medical records. If possible, consider 1-2 ovulation induction attempts domestically first to confirm ovarian response before deciding to go abroad.
Comments (0)